Roche’s HER2 Companion Diagnostic for Breast Cancer: FDA approval Kumar Jeetendra | July 30, 2020 Roche, Basel, Switzerland, has received FDA approval for its Ventana HER2 Dual ISH DNA Probe Cocktail assay for the detection of the human epidermal growth factor receptor 2 (HER2) biomarker in breast cancer and as a companion diagnostic for Herceptin (trastuzumab) therapy. HER2 is an important biomarker sometimes found in breast cancer, and its detection …
